CooperCompanies Announces Third Quarter 2025 Results

About this update from The Cooper Companies, Inc.

[{"type":"text","content":"SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2025. Revenue increased 6% year-over-year to $1,060.3 million. CooperVision (CVI) revenue up 6% to $718.4 million, and CooperSurgical (CSI) revenue up 4% to $341.9 million.GAAP diluted earnings per share (EPS) of $0.49, down $0.03 or 6% from last year's third quarter.Non-GAAP diluted EPS of $1.10, up $0.14 or 15% from last year's third quarter. See \"Reconciliation of Selected GAAP Results to Non-GAAP Results\" below. Commenting on the results, Al White, CooperCompanies' President and CEO said, \"I am pleased to report that we delivered strong margins, double-digit earnings growth, and robust free cash flow reflecting the operational excellence that remains central to our growth strategy. Our revenues were below expectations but we're raising earnings guidance to reflect our operational performance and expect improving revenue in Q4 and in fiscal 2026 driven by MyDAY®. We remain confident in our strategy and ability to deliver long-term shareholder value.\" Third Quarter Operating Results Revenue of $1,060.3 million, up 6% from last year’s third quarter, up 3% in constant currency, up 2% organically.Gross margin of 65% compared with 66% in last year’s third quarter driven primarily by a product line exit at CooperSurgical. On a non-GAAP basis, gross margin was up 70 basis points from last year at 67% driven by continued efficiency gains, favorable mix, and positive foreign exchange.Operating margin of 17% compared with 19% in last year’s third quarter driven primarily by a product line exit at CooperSurgical. On a non-GAAP basis, operating margin was up 60 basis points from last year at 26% on stronger gross margin and targeted expense leverage, offset by an increase in research and development expense.Interest expense of $25.4 million compared with $28.5 million in last year's third quarter driven by lower average interest rates and lower average debt. On a non-GAAP basis, interest expense was $24.7 million, down from $27.1 million.Cash provided by operations of $261.5 million offset by capital expenditures of $96.9 million resulted in free cash flow of $164.6 million. Third Quarter CooperVision (CVI) Revenue Revenue of $718.4 m...

More updates from The Cooper Companies, Inc.